| abstract |
NO gas (gNO) at a concentration of at least 160 ppm, for use in the treatment of a human subject suffering from a disease or disorder manifesting in the respiratory tract or a disease or disorder that can be treated via the airways respiratory, in which the human subject is an infant, the disease or disorder is bronchiolitis, and gNO is administered to the human subject intermittently, wherein intermittent inhalation comprises at least one continuous inhalation cycle of said gNO for a first period of time, followed by inhalation of no gNO for a second period of time. |